Dow Up0.05% Nasdaq Up0.04%

More On ABPI


Accentia Biopharmaceuticals, Inc. (ABPI)

-Other OTC
0.00 0.00(0.00%) Sep 16
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2012Sep 30, 2011Sep 30, 2010
Total Revenue 4,054   3,956   5,356  
Cost of Revenue2,770  2,490  2,901  
Gross Profit 1,285   1,466   2,455  
Operating Expenses
Research Development5,236  2,231  1,304  
Selling General and Administrative7,547  20,377  4,341  
Non Recurring40  30  415  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (11,538) (21,172) (3,604)
Income from Continuing Operations
Total Other Income/Expenses Net7,019  13,438  (27,136)
Earnings Before Interest And Taxes(10,135)(20,090)(31,791)
Interest Expense7,908  8,093  16,660  
Income Before Tax(18,044)(28,184)(48,451)
Income Tax Expense -  5  3  
Minority Interest4,865  4,100  412  
Net Income From Continuing Ops(12,428)(15,827)(46,992)
Non-recurring Events
Discontinued Operations3,240  179  (807)
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (9,188) (15,648) (47,799)
Preferred Stock And Other Adjustments -   -  (2,333)
Net Income Applicable To Common Shares (4,322) (11,553) (50,131)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.